241.67
0.08%
0.1188
前日終値:
$241.55
開ける:
$242.52
24時間の取引高:
82,093
Relative Volume:
0.09
時価総額:
$35.10B
収益:
$4.81B
当期純損益:
$1.11B
株価収益率:
39.23
EPS:
6.16
ネットキャッシュフロー:
$1.35B
1週間 パフォーマンス:
+4.45%
1か月 パフォーマンス:
+0.70%
6か月 パフォーマンス:
+10.75%
1年 パフォーマンス:
+58.49%
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
RMD | 241.62 | 35.10B | 4.81B | 1.11B | 1.35B | 6.16 |
ISRG | 547.63 | 191.57B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX | 225.03 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC | 85.78 | 42.29B | 9.76B | 1.16B | 665.00M | 0.72 |
WST | 315.36 | 22.14B | 2.88B | 499.60M | 321.60M | 7.41 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2023-09-06 | アップグレード | Needham | Hold → Buy |
2023-09-05 | ダウングレード | UBS | Buy → Neutral |
2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2023-05-23 | 開始されました | UBS | Buy |
2023-04-14 | 開始されました | Mizuho | Buy |
2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2022-04-06 | 開始されました | Wolfe Research | Outperform |
2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
2022-01-31 | アップグレード | Goldman | Neutral → Buy |
2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
2022-01-13 | アップグレード | CLSA | Outperform → Buy |
2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
2021-08-02 | ダウングレード | Needham | Buy → Hold |
2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
2021-06-22 | 開始されました | Robert W. Baird | Neutral |
2021-06-21 | 繰り返されました | Needham | Buy |
2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
2021-06-09 | アップグレード | CLSA | Sell → Outperform |
2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
2021-03-16 | アップグレード | Needham | Hold → Buy |
2020-11-02 | アップグレード | UBS | Neutral → Buy |
2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-02-03 | 開始されました | CLSA | Underperform |
2020-01-31 | ダウングレード | UBS | Buy → Neutral |
2020-01-10 | 開始されました | Oppenheimer | Perform |
2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2019-07-29 | アップグレード | UBS | Neutral → Buy |
2019-07-16 | ダウングレード | UBS | Buy → Neutral |
2019-05-06 | アップグレード | UBS | Neutral → Buy |
2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Resmed Inc Announces Upcoming Stock Sale - MSN
ResMed Inc. Officer Plans Major Stock Sale - MSN
Caprock Group LLC Acquires 2,806 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Acquired by Natixis Advisors LLC - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Acquired by Empowered Funds LLC - MarketBeat
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year - MSN
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) - Yahoo Finance
3,041 Shares in ResMed Inc. (NYSE:RMD) Acquired by Retireful LLC - MarketBeat
Meeder Asset Management Inc. Buys 3,174 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
3 ASX shares Australians can buy and hold for the next decade - MSN
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Second Half Financial Partners LLC Takes Position in ResMed Inc. (NYSE:RMD) - MarketBeat
LGT Capital Partners LTD. Decreases Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
LMR Partners LLP Sells 18,741 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Top broker says buy ResMed and this ASX 200 share - MSN
Publication relating to transparency notifications, Business Wires News - AsiaOne
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
Publication relating to transparency notifications - The Manila Times
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
ResMed Inc. (NYSE:RMD) Shares Acquired by Mawer Investment Management Ltd. - MarketBeat
ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders - Yahoo Finance
Victory Capital Management Inc. Has $28.49 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed (ASX:RMD) 3-Year EBITDA Growth Rate : 11.10% (As of Sep. 2024) - GuruFocus.com
KBC Group NV Increases Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
What is Zacks Research's Forecast for ResMed Q1 Earnings? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Position in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
Insider Sale: Director Witte De Sells Shares of ResMed Inc (RMD) - GuruFocus.com
ResMed director Jan De Witte sells shares worth $198,052 - Investing.com
ResMed Inc Insider Sells Shares, Retains Ownership - MSN
What is Zacks Research's Forecast for ResMed Q2 Earnings? - MarketBeat
Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness - Yahoo Finance Australia
Baillie Gifford & Co. Lowers Stake in ResMed Inc. (NYSE:RMD) - MarketBeat
Versor Investments LP Sells 2,400 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed CFO Brett Sandercock sells $249,000 in stock - Investing.com India
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
OVERSEA CHINESE BANKING Corp Ltd Has $4.75 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Entropy Technologies LP Invests $1.87 Million in ResMed Inc. (NYSE:RMD) - MarketBeat
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why - Simply Wall St
ResMed’s Peter Farrell Adjusts Stock Holdings - TipRanks
ResMed Inc Director Adjusts Stock Holdings - TipRanks
ResMed’s Executive Stock Transactions Highlight Compensation Practices - TipRanks
ResMed Inc. CEO Executes Strategic Stock Transactions - TipRanks
ResMed Inc’s Executive Share Transactions Revealed - TipRanks
ResMed CFO Sandercock Sells 1,000 Shares - TipRanks
ResMed Updates Dividend Details for ASX CDI Holders - TipRanks
Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed - Yahoo Finance
ResMed Inc. (NYSE:RMD) Shares Bought by Principal Financial Group Inc. - MarketBeat
Los Angeles Capital Management LLC Lowers Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):